191 related articles for article (PubMed ID: 35225600)
1. Improved Polymer Hemocompatibility for Blood-Contacting Applications via
Griffin L; Douglass M; Goudie M; Hopkins SP; Schmiedt C; Handa H
ACS Appl Mater Interfaces; 2022 Mar; 14(9):11116-11123. PubMed ID: 35225600
[TBL] [Abstract][Full Text] [Related]
2. Improved hemocompatibility of silicone rubber extracorporeal tubing via solvent swelling-impregnation of S-nitroso-N-acetylpenicillamine (SNAP) and evaluation in rabbit thrombogenicity model.
Brisbois EJ; Major TC; Goudie MJ; Bartlett RH; Meyerhoff ME; Handa H
Acta Biomater; 2016 Jun; 37():111-9. PubMed ID: 27095484
[TBL] [Abstract][Full Text] [Related]
3. Effect of varying nitric oxide release to prevent platelet consumption and preserve platelet function in an in vivo model of extracorporeal circulation.
Skrzypchak AM; Lafayette NG; Bartlett RH; Zhou Z; Frost MC; Meyerhoff ME; Reynolds MM; Annich GM
Perfusion; 2007 May; 22(3):193-200. PubMed ID: 18018399
[TBL] [Abstract][Full Text] [Related]
4. The attenuation of platelet and monocyte activation in a rabbit model of extracorporeal circulation by a nitric oxide releasing polymer.
Major TC; Brant DO; Reynolds MM; Bartlett RH; Meyerhoff ME; Handa H; Annich GM
Biomaterials; 2010 Apr; 31(10):2736-45. PubMed ID: 20042236
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide releasing Tygon materials: studies in donor leaching and localized nitric oxide release at a polymer-buffer interface.
Joslin JM; Lantvit SM; Reynolds MM
ACS Appl Mater Interfaces; 2013 Oct; 5(19):9285-94. PubMed ID: 23957655
[TBL] [Abstract][Full Text] [Related]
6. Catalyzed Nitric Oxide Release Via Cu Nanoparticles Leads to an Increase in Antimicrobial Effects and Hemocompatibility for Short Term Extracorporeal Circulation.
Douglass ME; Goudie MJ; Pant J; Singha P; Hopkins S; Devine R; Schmiedt CW; Handa H
ACS Appl Bio Mater; 2019 Jun; 2(6):2539-2548. PubMed ID: 33718805
[TBL] [Abstract][Full Text] [Related]
7. The effect of a polyurethane coating incorporating both a thrombin inhibitor and nitric oxide on hemocompatibility in extracorporeal circulation.
Major TC; Brisbois EJ; Jones AM; Zanetti ME; Annich GM; Bartlett RH; Handa H
Biomaterials; 2014 Aug; 35(26):7271-85. PubMed ID: 24927680
[TBL] [Abstract][Full Text] [Related]
8. S-Nitrosoglutathione-Based Nitric Oxide-Releasing Nanofibers Exhibit Dual Antimicrobial and Antithrombotic Activity for Biomedical Applications.
Douglass M; Hopkins S; Pandey R; Singha P; Norman M; Handa H
Macromol Biosci; 2021 Jan; 21(1):e2000248. PubMed ID: 33021079
[TBL] [Abstract][Full Text] [Related]
9. Development and hemocompatibility testing of nitric oxide releasing polymers using a rabbit model of thrombogenicity.
Major TC; Handa H; Annich GM; Bartlett RH
J Biomater Appl; 2014 Oct; 29(4):479-501. PubMed ID: 24934500
[TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of the safe margin, antithrombotic and antiproliferative actions for the treatment of restenosis: Nitric oxide donor and polymers.
Sorragi Cde L; Shishido SM; Lemos ME; Marcondes S; Antunes E; Krieger MH
Cell Biochem Funct; 2011 Apr; 29(3):207-14. PubMed ID: 21374644
[TBL] [Abstract][Full Text] [Related]
11. The Effects of the Combined Argatroban/Nitric Oxide-Releasing Polymer on Platelet Microparticle-Induced Thrombogenicity in Coated Extracorporeal Circuits.
Bellomo TR; Jeakle MA; Meyerhoff ME; Bartlett RH; Major TC
ASAIO J; 2021 May; 67(5):573-582. PubMed ID: 33902103
[TBL] [Abstract][Full Text] [Related]
12. In vitro investigation of the effect of plasticizers on the blood compatibility of medical grade plasticized poly (vinyl chloride).
Zhong R; Wang H; Wu X; Cao Y; He Z; He Y; Liu J
J Mater Sci Mater Med; 2013 Aug; 24(8):1985-92. PubMed ID: 23686353
[TBL] [Abstract][Full Text] [Related]
13. A dual-action nitric oxide-releasing slippery surface for extracorporeal organ support: Dynamic in vitro hemocompatibility evaluation.
Roberts TR; Harea GT; Zang Y; Devine RP; Maffe P; Handa H; Batchinsky AI
J Biomed Mater Res B Appl Biomater; 2023 Apr; 111(4):923-932. PubMed ID: 36404401
[TBL] [Abstract][Full Text] [Related]
14. Development of
Feit CG; Chug MK; Brisbois EJ
ACS Appl Bio Mater; 2019 Oct; 2(10):4335-4345. PubMed ID: 35021448
[TBL] [Abstract][Full Text] [Related]
15. Thrombogenicity is not reduced when heparin and phospholipid bonded circuits are used in a rabbit model of extracorporeal circulation.
Meinhardt JP; Annich GM; Miskulin J; Kawai T; Ashton BA; Bartlett RH
ASAIO J; 2003; 49(4):395-400. PubMed ID: 12918580
[TBL] [Abstract][Full Text] [Related]
16. Time lasting S-nitrosoglutathione polymeric nanoparticles delay cellular protein S-nitrosation.
Wu W; Gaucher C; Diab R; Fries I; Xiao YL; Hu XM; Maincent P; Sapin-Minet A
Eur J Pharm Biopharm; 2015 Jan; 89():1-8. PubMed ID: 25448077
[TBL] [Abstract][Full Text] [Related]
17. The mediation of platelet quiescence by NO-releasing polymers via cGMP-induced serine 239 phosphorylation of vasodilator-stimulated phosphoprotein.
Major TC; Handa H; Brisbois EJ; Reynolds MM; Annich GM; Meyerhoff ME; Bartlett RH
Biomaterials; 2013 Nov; 34(33):8086-96. PubMed ID: 23906514
[TBL] [Abstract][Full Text] [Related]
18. [Influence of S-nitrosoglutathione on agglutination and nitric oxide concentration in frozen platelets].
Wu T; Liu JH; Li H; Zhou W; Wang SY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):386-9. PubMed ID: 22541104
[TBL] [Abstract][Full Text] [Related]
19. The hemocompatibility of a nitric oxide generating polymer that catalyzes S-nitrosothiol decomposition in an extracorporeal circulation model.
Major TC; Brant DO; Burney CP; Amoako KA; Annich GM; Meyerhoff ME; Handa H; Bartlett RH
Biomaterials; 2011 Sep; 32(26):5957-69. PubMed ID: 21696821
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation polyvinyl chloride extracorporeal circulation catheters for heparin-free treatment.
Liu Y; Han Q; Li G; Lin H; Liu F; Li Q; Deng G
J Mater Chem B; 2022 Oct; 10(40):8302-8314. PubMed ID: 36165336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
